[1]
“In Silico Designing, ADMET Screening, MM/GBSA Binding Free Energy of Some Novel 8-Amino Substituted Apigenin Derivatives as DPP-IV Inhibitors Targeting Type-II Diabetes Mellitus”, Journal of Pharmaceutical Negative Results, vol. 13, pp. 2719–2729, Dec. 2022, doi: 10.47750/pnr.2022.13.S05.418.